Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
US okays nasal spray flu vaccine for self-use
US approves first nasal spray flu vaccine that can be self-administered
FluMist is the first vaccine to prevent influenza, more commonly known as the flu, that does not need to be administered by a health care provider.
At-home nasal spray flu vaccine coming next year
A nasal spray flu vaccine for people up to 49 will be available for home use starting in the fall of 2025 after the Food and Drug Administration expanded its approval of AstraZeneca's FluMist. Why it matters: It will be the first flu vaccine that doesn't need to be administered by a health provider and will be sold direct to consumers for home use via an online pharmacy.
FDA approves ‘FluMist,' says no healthcare provider needed
FluMist is the first vaccine to prevent influenza that does not need to be administered by a healthcare provider, the regulator said.
FDA approves FluMist for upcoming flu season
The Food and Drug Administration announced on Friday an approval of a new self- and caregiver-administered nose spray against the flu.
FDA approves first self-administered flu vaccine spray
The Food and Drug Administration announced Friday it had broadened the approval of the FluMist nasal spray to become the first "self-administered" influenza vaccine — though a delay in the change means the vaccine will not be available to ship to homes until next year's flu season at the earliest.
FDA approves first at-home flu vaccine in U.S., a nasal spray
FluMist is the only flu vaccine administered by nasal spray, not injection. It is licensed for individuals between the ages of 2 and 49. This FDA approval makes it the only flu vaccine in the United States that can be administered at home and that does not need to be administered by a health care professional.
US FDA approves AstraZeneca’s needle-free nasal spray, FluMist for self-administration
US FDA approves AstraZeneca’s needle-free nasal spray, FluMist for self-administration: Cambridge, UK Monday, September 23, 2024, 09:00 Hrs [IST] AstraZeneca, a global, science-
FDA Approves FluMist Nasal Spray Influenza Vaccine for Self- or Caregiver-Administration
First Influenza Vaccine That Does Not Need to be Administered by a Health Care Provider
FluMist Becomes First At-Home Self-Administered Flu Vaccine Approved by FDA
FluMist, a needle-free nasal spray influenza vaccine, has been approved by the FDA for self-administration in the US, making it the first flu vac
FDA approves first flu vaccine that can be self-administered at home
FluMist is a nasal spray manufactured by AstraZeneca that has been used to protect against influenza in the United States since 2003.
FDA approves at-home flu vaccine that is 'really effective': Dr. Ghandi | NewsNation Now
The FDA approved an at-home flu vaccine in the form of a nasal spray that Dr., Monica Ghandi, UCSD Associate Division Chief of Infectious Diseases, says must be prescribed. Ghandi describes the vaccine and says it is “not painful,
25m
on MSN
You can get an at-home flu ‘shot’ starting next year
The spray could be an alternative for people who are averse to getting injections, or otherwise find it difficult or ...
Yahoo Finance
9h
FDA approves AstraZeneca FluMist ‘flu vaccine for self-administration
The US Food and Drug Administration (FDA) has approved AstraZeneca's
FluMist
, a needle-free nasal spray influenza vaccine ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Trending now
Alabama mass shooting
Daylight saving time
Visits US ammunition plant
Israeli strikes in Lebanon
Trump to campaign in MI
California plastic bag ban
Economic speech this week
Robinson loses key staff
Ga. suspect's mom indicted
San Francisco homelessness
Donlon's homes searched
Released after guilty plea
Drug price challenge revived
Former WA governor dies
No. 1 at box office again
TN abortion law blocked
Boeing defense chief exits
ISR raids Al Jazeera office
SC 1st execution in 13 years
CA firefighter held for arson
Suns broadcaster dies
Biden hosts 'Quad' summit
No govt. shutdown for now
Iran coal mine blast
Sesame Place suit verdict
CA bill to protect kids online
J&J unit files for bankruptcy
Dolphins legend Morris dies
Free COVID-19 tests
PM Modi visits US
Related topics
AstraZeneca
Nasal spray
Food and Drug Administration
MedImmune
Live attenuated influenza vaccine
Feedback